cbdMD Inc YCBD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.90
- Day Range
- $0.86–0.95
- 52-Week Range
- $0.56–4.62
- Bid/Ask
- $0.87 / $0.96
- Market Cap
- $2.65 Mil
- Volume/Avg
- 59,960 / 277,717
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.09
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD and hempMD. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD bath bombs, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 52
- Website
- https://www.cbdmd.com
Valuation
|
Metric
|
YCBD
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.37 |
Price/Sales | 0.09 |
Price/Cash Flow | — |
Price/Earnings
YCBD
Financial Strength
|
Metric
|
YCBD
|
|---|---|
Quick Ratio | 0.44 |
Current Ratio | 1.23 |
Interest Coverage | — |
Quick Ratio
YCBD
Profitability
|
Metric
|
YCBD
|
|---|---|
Return on Assets (Normalized) | 24.25% |
Return on Equity (Normalized) | 34.43% |
Return on Invested Capital (Normalized) | 28.13% |
Return on Assets
YCBD
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Bqblytmynz | Mjmsh | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Fbzyfmfpz | Hhbfr | $70.8 Bil | |
HLN
| Haleon PLC ADR | Zsgwnvls | Bnbx | $37.7 Bil | |
VTRS
| Viatris Inc | Vrcnqst | Qcgvt | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Vxtpxvzb | Pyzfr | $12.5 Bil | |
CTLT
| Catalent Inc | Xgpdpbwf | Fbbzhr | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Qsbqztrwx | Jmzk | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Rprdttmgx | Yld | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Bxrxstbkg | Qvysng | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Fcfcjkntzx | Mwvr | $2.9 Bil |